লোডিং…
The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial
BACKGROUND: Mild cognitive impairment (MCI) is an intermediate phase between normal aging and dementia. Since a majority of amnestic MCI (aMCI) cases progress to Alzheimer’s disease (AD), it is considered the prodromal stage of AD and, therefore, a treatment target for the prevention of further cogn...
প্রধান লেখক: | , , , , , , |
---|---|
বিন্যাস: | Online প্রবন্ধ পাঠ্য |
ভাষা: | English |
প্রকাশিত: |
BioMed Central
2019
|
বিষয়গুলি: | |
অনলাইন ব্যবহার করুন: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647292/ https://www.ncbi.nlm.nih.gov/pubmed/31331367 http://dx.doi.org/10.1186/s13063-019-3567-1 |